These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aging: effect on ex-vivo benzodiazepine binding after a diazepam injection. Komiskey HL Neurochem Res; 1987 Aug; 12(8):745-9. PubMed ID: 2888034 [TBL] [Abstract][Full Text] [Related]
4. Like diazepam, CL 218,872, a selective ligand for the benzodiazepine omega 1 receptor subtype, impairs place learning in the Morris water maze. McNamara RK; Skelton RW Psychopharmacology (Berl); 1992; 107(2-3):347-51. PubMed ID: 1352055 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ Behav Pharmacol; 1999 Sep; 10(5):483-95. PubMed ID: 10780255 [TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine receptors: preferential stimulation of Type 1 receptors by pentobarbital. Niehoff DL; Mashal RD; Kuhar MJ Eur J Pharmacol; 1983 Aug; 92(1-2):131-4. PubMed ID: 6313382 [TBL] [Abstract][Full Text] [Related]
7. Tofizopam modulates the affinity of benzodiazepine receptors in the rat brain. Saano V; Urtti A Pharmacol Biochem Behav; 1982 Aug; 17(2):367-9. PubMed ID: 6127722 [TBL] [Abstract][Full Text] [Related]
8. The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist. Yasumatsu H; Morimoto Y; Yamamoto Y; Takehara S; Fukuda T; Nakao T; Setoguchi M Br J Pharmacol; 1994 Apr; 111(4):1170-8. PubMed ID: 7913372 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of type 1 and type 2 benzodiazepine receptors in the ovine brain. Villiger JW; Taylor KM; Gluckman PD Pharmacol Biochem Behav; 1982 Mar; 16(3):373-5. PubMed ID: 6281813 [TBL] [Abstract][Full Text] [Related]
10. The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo. Keane PE; Simiand J; Morre M Neurosci Lett; 1984 Mar; 45(1):89-93. PubMed ID: 6145125 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on synthetic flavonoids: comparison with diazepam. Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415 [TBL] [Abstract][Full Text] [Related]
12. F 2692: flumazenil-reversible anxiolytic effects but inactive on [3H]-Ro 15-4513 binding. File SE; Andrews N Pharmacol Biochem Behav; 1994 May; 48(1):223-7. PubMed ID: 7913225 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic profile of a new anxiolytic, DN-2327: effect of Ro15-1788 and interaction with diazepam in rodents. Wada T; Fukuda N Psychopharmacology (Berl); 1991; 103(3):314-22. PubMed ID: 1676179 [TBL] [Abstract][Full Text] [Related]
15. Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities. Chambon JP; Perio A; Demarne H; Hallot A; Dantzer R; Roncucci R; Bizière K Arzneimittelforschung; 1985; 35(10):1573-7. PubMed ID: 2866771 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic demonstration of the selectivity of two 1-N-trifluoroethyl benzodiazepines for the BZD-1 receptors in the rat brain. Wamsley JK; Golden JS; Yamamura HI; Barnett A Pharmacol Biochem Behav; 1985 Dec; 23(6):973-8. PubMed ID: 2867566 [TBL] [Abstract][Full Text] [Related]